Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Aytu BioPharma (AYTU)

Annual Return

Over the past 3 years, AYTU has had an average annual return of +0%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, AYTU has had an average annual return of -80.26%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Feb 1, 2017, AYTU has had an average annual return of -78.85%, underperforming the benchmark SPY, which returned +15.50% annual.

2023202220212020201920182017
+0%-66.67%-80.00%-37.50%+20%-98.21%-88.85%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+0%+0%
2022+0%+0%+0%-33.33%-50.00%+100%-50.00%+0%+0%+0%+0%+0%-66.67%
2021+20%+5.56%-0%-10.53%-23.53%-0%-23.08%+0%-30.00%-14.29%-16.67%-40.00%-80.00%
2020-25.00%-27.78%+192.31%+7.89%-9.76%-2.70%-2.78%-22.86%+11.11%-20.00%-8.33%-31.82%-37.50%
2019+50%-3.33%+44.83%+21.43%-21.57%+17.50%-17.02%-10.26%-14.29%-13.33%-19.23%+14.29%+20%
2018+30.49%-78.01%+0%-26.56%-27.66%-23.53%+30.77%-36.47%-36.11%-60.87%-7.41%-20.00%-98.21%
2017-6.00%-4.26%-16.67%-13.33%-9.23%-1.69%-67.67%+6.67%-17.50%-13.94%-21.48%-88.85%

Drawdown analysis of Aytu BioPharma (AYTU)

The maximum drawdown for the AYTU was -99.99%, occurring on May 6, 2022. This drawdown has not yet recovered.

The current AYTU drawdown is -99.99%.

Since Feb 1, 2017 AYTU has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Feb 8, 20171311May 6, 2022OngoingOngoingOngoing
-11.00%Feb 1, 20174Feb 7, 20171Feb 8, 20175